Business Context and Reporting Period
This Form 8-K is filed by Hemispherx Biopharma, Inc. (not AIM Immunotech Inc.) on March 1, 2016, reporting an event that occurred on February 29, 2016. The filing addresses an amendment to the Company's 2016 Senior Executive Deferred Cash Performance Award Plan.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation arrangements.
Material Changes
The Compensation Committee approved an amendment to the deferred cash plan for Thomas K. Equels (CEO, President, Executive Vice Chairman, Secretary, and General Counsel). The key changes are:
- Withholding Increase: For the payroll periods ended February 15 and 29, 2016, 50% of Mr. Equels' compensation was withheld. For the remainder of the initial 3-month period (commencing February 1, 2016), the withholding rate increased to 100%.
- Future Terms: Following the initial period, at least 50% of compensation shall be withheld, with any excess amount subject to agreement between the Committee and Mr. Equels.
- Tax Exclusion: Amounts withheld after March 1, 2016, will exclude the necessary after-tax amounts to fund FICA, FUTA, and other governmental welfare benefit taxes, as well as health or insured benefits for which Mr. Equels contributes.
Management Commentary and Rationale
Management stated that the Plan was originally established to conserve cash and align executive incentives with company performance. Mr. Equels agreed to increase his withholding from 50% to 100% to "fully align his compensation with his ability to increase stockholder value."
Investor Verification Checklist
- Verify the exact impact of the 100% withholding on the Company's immediate cash flow conservation.
- Review the attached Exhibit 10.1 (Amended and Restated 2016 Senior Executive Deferred Cash Performance Award Plan) for full legal terms.
- Confirm the duration of the "Initial Period" and the specific conditions for future withholding percentages.
- Check subsequent filings for any further changes to executive compensation or cash position.